NEW YORK CITY, NY / ACCESS Newswire / March 10, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ramaco Resources, Inc. (NASDAQ:METC) between July 31, 2025 and October 23, 2025, both dates inclusive (the "Class Period"), of the important March 31, 2026 lead plaintiff deadline. SO […]
NEW YORK CITY, NY / ACCESS Newswire / March 10, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Richtech Robotics Inc. (NASDAQ:RR) between January 27, 2026 and 12:00 PM ET on January 29, 2026, both dates inclusive (the "Class Period"), of the important April 3, 2026
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) common stock between August 3, 2023 and December 26, 2025. Ultragenyx is a biopharmaceutical company focused on rare and ultrarare
NEW YORK CITY, NY / ACCESS Newswire / March 10, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Trip.com Group Limited (NASDAQ:TCOM) resulting from allegations that Trip.com may have issued materially misleading business information to the investing public. SO WHAT:
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Paysafe Limited (NYSE:PSFE) securities between March 4, 2025 and November 12, 2025. Paysafe provides end-to-end payment solutions in the United States and internationally. For
NEW YORK CITY, NY / ACCESS Newswire / March 10, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Oracle Corporation (NYSE:ORCL) between June 12, 2025, and December 16, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline. SO WHAT: If
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ:MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Kyndryl Holdings, Inc. (NYSE:KD) securities between August 7, 2024 and February 9, 2026. Kyndryl describes itself as a "technology services company, which engages in
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ:INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and
NEW YORK CITY, NY / ACCESS Newswire / March 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PROCEPT BioRobotics Corporation ("PROCEPT" or "the Company") (NASDAQ:PRCT). Investors who purchased PROCEPT securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PRCT.